These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24374553)

  • 1. Variations in central serotonergic activity - relevance of the 5-HTTLPR, life events and their interaction.
    Wielpuetz C; Kuepper Y; Grant P; Munk AJ; Hennig J
    Behav Brain Res; 2015 Jan; 277():245-53. PubMed ID: 24374553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonin transporter gene length polymorphism (5-HTTLPR) and life events: no evidence for an interaction effect on neuroticism and anxious depressive symptoms.
    Middeldorp CM; de Geus EJ; Willemsen G; Hottenga JJ; Slagboom PE; Boomsma DI
    Twin Res Hum Genet; 2010 Dec; 13(6):544-9. PubMed ID: 21142930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute responsivity of the serotonergic system to S-citalopram and positive emotionality-the moderating role of the 5-HTTLPR.
    Wielpuetz C; Kuepper Y; Grant P; Munk AJ; Hennig J
    Front Hum Neurosci; 2013; 7():486. PubMed ID: 23986679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
    Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
    Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderation of antidepressant response by the serotonin transporter gene.
    Huezo-Diaz P; Uher R; Smith R; Rietschel M; Henigsberg N; Marusic A; Mors O; Maier W; Hauser J; Souery D; Placentino A; Zobel A; Larsen ER; Czerski PM; Gupta B; Hoda F; Perroud N; Farmer A; Craig I; Aitchison KJ; McGuffin P
    Br J Psychiatry; 2009 Jul; 195(1):30-8. PubMed ID: 19567893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin transporter polymorphism alters citalopram effects on human pain responses to physical pain.
    Ma Y; Wang C; Luo S; Li B; Wager TD; Zhang W; Rao Y; Han S
    Neuroimage; 2016 Jul; 135():186-96. PubMed ID: 27132044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life stress, 5-HTTLPR and mental disorder: findings from a 30-year longitudinal study.
    Fergusson DM; Horwood LJ; Miller AL; Kennedy MA
    Br J Psychiatry; 2011 Feb; 198(2):129-35. PubMed ID: 21282783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.
    Smits K; Smits L; Peeters F; Schouten J; Janssen R; Smeets H; van Os J; Prins M
    Int Clin Psychopharmacol; 2007 May; 22(3):137-43. PubMed ID: 17414739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of 5-HTTLPR (serotonin transporter) and tryptophan hydroxylase 2 G-703T gene polymorphisms on the clinical response to citalopram among children and adolescents with depression and anxiety disorders.
    Rotberg B; Kronenberg S; Carmel M; Frisch A; Brent D; Zalsman G; Apter A; Weizman A
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):117-22. PubMed ID: 23510446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-by-environment interaction for panic disorder.
    Choe AY; Kim B; Lee KS; Lee JE; Lee JY; Choi TK; Lee SH
    Neuropsychobiology; 2013; 67(4):192-200. PubMed ID: 23635830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases.
    Capozzo MA; Schillani G; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
    Tumori; 2009; 95(4):479-83. PubMed ID: 19856660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
    Lewis G; Mulligan J; Wiles N; Cowen P; Craddock N; Ikeda M; Grozeva D; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Peters TJ
    Br J Psychiatry; 2011 Jun; 198(6):464-71. PubMed ID: 21263010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial difficulties but not other types of recent negative life events show strong interactions with 5-HTTLPR genotype in the development of depressive symptoms.
    Gonda X; Eszlari N; Kovacs D; Anderson IM; Deakin JF; Juhasz G; Bagdy G
    Transl Psychiatry; 2016 May; 6(5):e798. PubMed ID: 27138797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.
    Grabe HJ; Schwahn C; Mahler J; Appel K; Schulz A; Spitzer C; Fenske K; Barnow S; Freyberger HJ; Teumer A; Petersmann A; Biffar R; Rosskopf D; John U; Völzke H
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):264-70. PubMed ID: 21996278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effects of the 5-HTTLPR and 5-HTR1A genes modulates the relationship between negative life events and major depressive disorder in a Chinese population.
    Zhang K; Xu Q; Xu Y; Yang H; Luo J; Sun Y; Sun N; Wang S; Shen Y
    J Affect Disord; 2009 Apr; 114(1-3):224-31. PubMed ID: 18848359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of chronic stress with serotonin transporter and catechol-O-methyltransferase polymorphisms in predicting youth depression.
    Conway CC; Hammen C; Brennan PA; Lind PA; Najman JM
    Depress Anxiety; 2010 Aug; 27(8):737-45. PubMed ID: 20577990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
    Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
    Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.